These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 34850765

  • 1. The value of contrast-enhanced ultrasound and magnetic resonance imaging in the diagnosis of bladder cancer.
    Li C, Gu Z, Ni P, Zhang W, Yang F, Li W, Yao X, Chen Y.
    J Cancer Res Ther; 2021 Nov; 17(5):1179-1185. PubMed ID: 34850765
    [Abstract] [Full Text] [Related]

  • 2. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
    Zhou G, Chen X, Zhang J, Zhu J, Zong G, Wang Z.
    Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
    [Abstract] [Full Text] [Related]

  • 3. The comparison between contrast-enhanced ultrasound and contrast-enhanced magnetic resonance imaging in diagnosing bladder urothelial carcinoma.
    Fu W, Liu D, Xiong Y, Liu C, Liu J, Yi X, Zhao T.
    Int Urol Nephrol; 2023 May; 55(5):1073-1079. PubMed ID: 36422743
    [Abstract] [Full Text] [Related]

  • 4. Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion.
    Lee M, Shin SJ, Oh YT, Jung DC, Cho NH, Choi YD, Park SY.
    Eur Radiol; 2017 Sep; 27(9):3752-3758. PubMed ID: 28168374
    [Abstract] [Full Text] [Related]

  • 5. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V, de Lutio di Castelguidone E, Fusco R, Catalano O, Piccirillo M, Palaia R, Izzo F, Gallipoli AD, Petrillo A.
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [Abstract] [Full Text] [Related]

  • 6. Combining the Arterial Phase of Contrast-Enhanced Ultrasonography, Gadoxetic Acid-Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging in the Diagnosis of Hepatic Nodules ≤20 mm in Patients with Cirrhosis.
    Zhou Y, Jing X, Zhang X, Ding J, Wang Y, Zhou H, Zhang Q, Chen Y, Yue W.
    Ultrasound Med Biol; 2019 Mar; 45(3):693-701. PubMed ID: 30606633
    [Abstract] [Full Text] [Related]

  • 7. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic efficacy of contrast-enhanced ultrasound for breast lesions of different sizes: a comparative study with magnetic resonance imaging.
    Li C, Yao M, Shao S, Li X, Li G, Wu R.
    Br J Radiol; 2020 Jun; 93(1110):20190932. PubMed ID: 32216631
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic Accuracy of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Muscle-Invasive Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis.
    Tufano A, Rosati D, Moriconi M, Santarelli V, Canale V, Salciccia S, Sciarra A, Franco G, Cantisani V, Di Pierro GB.
    Curr Oncol; 2024 Feb 01; 31(2):818-827. PubMed ID: 38392054
    [Abstract] [Full Text] [Related]

  • 10. Application of bi-planar reduced field-of-view DWI (rFOV DWI) in the assessment of muscle-invasiveness of bladder cancer.
    Meng X, Hu H, Wang Y, Hu D, Li Z, Feng C.
    Eur J Radiol; 2021 Mar 01; 136():109486. PubMed ID: 33434861
    [Abstract] [Full Text] [Related]

  • 11. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M, Horvat JV, Bernard-Davila B, Marino MA, Leithner D, Ochoa-Albiztegui RE, Helbich TH, Morris EA, Thakur S, Pinker K.
    J Magn Reson Imaging; 2019 Mar 01; 49(3):864-874. PubMed ID: 30375702
    [Abstract] [Full Text] [Related]

  • 12. Role of multiparametric magnetic resonance imaging in the diagnosis and staging of urinary bladder cancer.
    Shalaby EA, Mohamed AR, Elkammash TH, Abouelkheir RT, Housseini AM.
    Curr Urol; 2022 Sep 01; 16(3):127-135. PubMed ID: 36204360
    [Abstract] [Full Text] [Related]

  • 13. [Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection].
    Zhao SM, Yang TJ, Xu CM, Guo XF, Ma YK, Chen XJ, Li X, He CH.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug 18; 52(4):701-704. PubMed ID: 32773805
    [Abstract] [Full Text] [Related]

  • 14. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Makboul M, Farghaly S, Abdelkawi IF.
    Br J Radiol; 2019 Dec 18; 92(1104):20190401. PubMed ID: 31573328
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma.
    Ren J, Huan Y, Li F, Wang H, Ge Y, Chang Y, Yin H, Sun L.
    J Magn Reson Imaging; 2009 Aug 18; 30(2):351-6. PubMed ID: 19591203
    [Abstract] [Full Text] [Related]

  • 20. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.
    Shiozawa K, Watanabe M, Ikehara T, Matsukiyo Y, Kogame M, Kikuchi Y, Otsuka Y, Kaneko H, Igarashi Y, Sumino Y.
    J Clin Ultrasound; 2017 Mar 04; 45(3):138-144. PubMed ID: 27861987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.